about
Surgery versus radiosurgery for people with single or solitary brain metastasesSurgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastasesSurgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastasesWNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasisMolecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case PresentationThe role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosisRole of stereotactic radiosurgery in patients with more than four brain metastasesVenous thromboembolism in cancer patients: an underestimated major health problemEvolving management of symptomatic chronic subdural hematoma: experience of a single institution and review of the literatureMultifunctional nanoparticles for brain tumor imaging and therapy.Patients with single brain metastasis from non-small cell lung cancer equally benefit from stereotactic radiosurgery and surgery: a systematic reviewThe vascular basement membrane as "soil" in brain metastasisMelanoma Brain Metastasis: Mechanisms, Models, and MedicinePerillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain MetastasesSmall solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapySystemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.Radiotherapy of brain metastases from breast cancer: Treatment results and prognostic factors.Usefulness of double dose contrast-enhanced magnetic resonance imaging for clear delineation of gross tumor volume in stereotactic radiotherapy treatment planning of metastatic brain tumors: a dose comparison study.Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data.Advanced magnetic resonance imaging biomarkers of cerebral metastases.MRI Patterns of Isolated Lesions in the Medulla Oblongata.Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors.A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary.Utility of administrative claims data for the study of brain metastases: a validation study.Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regressionThe role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineThe role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineEvidence-based clinical practice parameter guidelines for the treatment of patients with metastatic brain tumors: introductionComparative survival in patients with brain metastases from non-small-cell lung cancer treated before and after implementation of radiosurgery3D radiation therapy boost improves the outcome of whole brain radiation therapy treated RPA II patients with one or two brain metastases.Brain metastasis-initiating cells: survival of the fittest.Computer-aided detection of brain metastasis on 3D MR imaging: Observer performance study.Distant brain recurrence in patients with five or more newly diagnosed brain metastases treated with focal stereotactic radiotherapy alone.Quantitative Analysis of the Spatial Distribution of Metastatic Brain LesionsEvaluation of clinical contributions provided by addition of the brain, calvarium, and scalp to the limited whole body imaging area in FDG-PET/CT tumor imaging.Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice.Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells.Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.Brain metastases from colorectal carcinoma: a description of 60 cases in a single Chinese cancer center.
P2860
Q24186215-440F6A1D-DAFC-4574-BF97-E57FE1F7F2F5Q24198129-90D040A1-F992-459D-B0EF-06B00D7C4BCDQ24235688-619F15E0-1EFB-414C-96A7-7EDDCFF5B547Q24310644-1F2E003D-9404-4ADC-8FB6-4E0C781CF127Q26800626-FEB4295D-B563-49C6-BB08-41891EF9E050Q26825055-BB25DE1F-E54E-40DC-B86E-BBAB293D5458Q26851819-915E61BB-92C1-4474-87F8-0FC35BEE22E5Q26852015-EC69591E-3C26-4014-9579-5BE1165B009DQ26862513-403997C3-748F-4ACB-9C6C-A608DDA35346Q26865418-1A1778C3-B30A-4CEC-96C7-A75775F8B8C6Q26865729-5B03B29A-1B81-44B5-BFDB-ABB9A1561413Q27348725-32891469-7863-4FB9-B7F6-5346EB5C1345Q28069421-CCEB41E5-35A5-4F61-97FD-C9EA4C12CD16Q28072442-31B8BE39-F2A3-4B74-818A-609CCBD882D4Q28390962-AB33747B-E655-425D-9442-4CF6C62ACF39Q30239901-53B447A7-AF0F-4833-AA09-F020765C91B9Q30315204-91E819C5-DC79-4556-9304-ACE77B8B4859Q30422997-E1183186-0990-4A8E-82F8-86498D3C555CQ30557877-A4136C22-DB6D-463E-BB13-B6ED87F70F25Q30560150-E53E1B90-7E1F-448C-9F29-1784965BAADBQ31101418-8EB26AD8-C480-4F2E-8E8B-E1005DC5A3A3Q33416431-473A61EF-9D91-4569-AD80-FAB3985B3103Q33438310-F36373C0-64F8-4531-ACB7-7E14A9109E06Q33475683-D0F0F157-22AB-4AA9-8033-27FE639217ADQ33551268-491D8A85-5C47-47F6-9C28-77294E15BD44Q33599104-DCC717A0-8EC4-4CE4-BFE4-51EBBE110B45Q33599111-958F627B-EC11-4798-97CF-059774C8397AQ33599118-3247492A-4AFE-401A-AC4E-56110552C970Q33599182-485A72C1-3855-4296-9440-A1345153AA4AQ33611167-1364C834-45F1-4EE1-9F15-9CEBE34EC9D0Q33755603-B1C56B64-4FC6-403D-9E68-A9FEE78D5928Q33755959-D3D0F57E-777E-4356-9C1C-0CFF20BF3840Q33778440-19CFD535-3EF4-4DA8-BA4D-9E2277C768ACQ33807248-B429E6BB-721E-4E97-ACF3-B73D9E3A1862Q33825719-EFE78854-053D-4CAB-BE62-B258FDAC1FBCQ33852867-C70E9D19-55D7-4B85-9653-C88BDCB040E4Q33862844-CF08B034-6A03-4B4C-9154-F73260BA0B96Q33924987-DEE50064-8D15-4820-B7E4-1005400DC00DQ33926135-ABAB63CA-81F1-4ABD-BC1E-2D8F621D206AQ34018126-2A7A87CC-9A77-4502-B918-EF456D2D09DE
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Brain metastases: epidemiology and pathophysiology.
@ast
Brain metastases: epidemiology and pathophysiology.
@en
type
label
Brain metastases: epidemiology and pathophysiology.
@ast
Brain metastases: epidemiology and pathophysiology.
@en
prefLabel
Brain metastases: epidemiology and pathophysiology.
@ast
Brain metastases: epidemiology and pathophysiology.
@en
P1476
Brain metastases: epidemiology and pathophysiology
@en
P2093
Jerome B Posner
P2888
P356
10.1007/S11060-004-8093-6
P577
2005-10-01T00:00:00Z